Ideagen Share Discussion Threads

[glasshalfull] 04/3/2014 08:41

Well done to DH and his team.

Nice reassuring update that confirms strength of business & excellent timing given the recent market volatility we've experienced as this should underpin the shareprice.

finnCap agree,

Ideagen has reported a trading update for the period to date, highlighting continuing strong performance in line with unchanged expectations for the second half and full year (April year end).

1H14 was characterised by contract wins with the NHS (Guys and St Thomas NHS Foundation is now the group's largest customer), while 2H14 has witnessed an increase in the number and value of commercial sector contract wins – such as RWE, Achmea, and BTG, showing success in a range of sectors and territories, with a combined total contract value of £500k.

NHS opportunities remain strong. Management has been strengthened by the combined experience of staff acquired with Pentana, assuming responsibilities within Ideagen in non board directorship roles; and the sales force has benefited from recruitment into the commercial sales team, as mentioned at interims. Momentum is positive."

---

Delighted to be a holder here.

Regards,
GHF

[cheshire man] 04/3/2014 08:24

I fully agree with you there bb, very pleased with this news and look forward to May,,,,

[battlebus2] 04/3/2014 08:16

Morning Cheshire Man, i said a while back 50p was a possibility here and this mornings update makes that target even more realistic imv.

[cheshire man] 04/3/2014 08:10

Positive TU this morning and an update to come in May informing us of the the profitable growth from the ingergration of Pentana :-0) IMO

[yump] 04/3/2014 07:29

Very nice.

[battlebus2] 04/3/2014 07:06

Great news this morning...

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces that trading in the second half of the current financial year has continued strongly with a significant increase in contract wins from the commercial sector.

Contract Wins
Whilst the first half of the current financial year delivered strong revenue growth due to contract wins with the NHS, the second half of the year has witnessed an increase in the number and value of new contracts from commercial customers. Of particular note are new contract wins at RWE, a top five European energy supplier, Achmea, the Netherlands leading insurance company and BTG, a growing international specialist healthcare company worth a combined value of approximately £500k.

Strengthening of Management and Sales Teams
The integration of Pentana is now complete and the Group has made a number of non-board management changes. Ken Ebbage, formerly Chief Executive of Pentana, has been appointed Managing Director, Product and Services for the Group's Risk and Compliance business and Terry Perkins, formerly Services Director of Pentana, has been appointed Product Director for Risk and Compliance. In addition, the company has recruited additional sales resource into the commercial team in order to capture the growing opportunity within this market segment.

Outlook
The Company expects the rest of the second half of the current financial year to benefit from the continued increase in commercial activities in addition to further NHS contract wins. In particular, Guys and St Thomas' NHS foundation trust is now the Group's latest NHS customer and we expect to announce further significant NHS contracts over the next two months.

David Hornsby, Chief Executive, commented: "I am delighted with progress so far in the second half. We are seeing increased momentum in our commercial business and the NHS remains a strong market for the Group. I am particularly pleased with the rapid integration of Pentana into the Group which has provided a great platform for profitable growth.

The Company therefore continues to trade in line with market expectations and looks forward to providing a further update in May following the end of the current financial period."

[yump] 24/2/2014 15:54

I've been wondering whether to go what would be overweight (for me). Particularly as I like the stability of the step increases in the chart. Not as some sort of magic predictor, but just because it seems to be saying that investors are quite secure with the current valuation.

Downside seems to me to be the potential changeability of the healthcare market / policies etc.

However IDEA by their acquisitions, should be stabilising the revenues. Which just leaves a growing market; so as long as they keep gaining contracts, the growth should keep on.

That's a bit simplistic, but nice to at least have a relatively simple business model to follow.

GHF will obviously know more details.

[jimbobaroony] 24/2/2014 15:46

Tempted to go for a few more of these. Looks a decent long term bet. Anyone care to highlight any major downsides or issues that I may be missing?

[simon gordon] 13/2/2014 10:29

Seemingly, Mirabeau doesn't even own any ACT shares but he's pumping it. Bizarre.

[yump] 13/2/2014 10:00

Posted apparently randomly on irrelevant threads.

[simon gordon] 13/2/2014 08:42

Mirabeau,

ACT are in a totally different market to IDEA.

[mirabeau] 13/2/2014 08:23

A similar company to IDEA that floated today is Actual Experience PLC (ACT)

IP Group have been raving about them..Good blue chip client base..Top notch board

[cheshire man] 13/2/2014 08:17

Well done indeed :-)

[glasshalfull] 13/2/2014 08:09

Another contract win in the healthcare market from IDEA



Ideagen Plc, a leading supplier of compliance based information management, is pleased to announce it has been awarded a contract with BTG, a growing international specialist healthcare company focused on acute care, cancer and vascular diseases.

Ideagen's contract with BTG is to implement a global integrated electronic document management and learning management system using Ideagen's Workbench Enterprise software. The hosted system will provide a web-based on-demand platform to manage the life-cycle and storage of quality documents, as well as supporting training of 800 BTG staff.

Ideagen will also provide a range of services to BTG: Implementation Services to ensure successful project delivery; round the clock Customer Support Services aligning with BTG's global operations; and specialist Validation Services assisting BTG with system testing and documentation ahead of full system validation by the appropriate regulatory organisations.

David Hornsby, Ideagen Chief Executive commented, "I am delighted that BTG has selected Ideagen for this significant global project. We look forward to working alongside the BTG team to implement the hosted and fully integrated Workbench Enterprise as well as learning management system as quickly as possible."

"This exciting news from our Governance Risk & Compliance (GRC) team comes alongside a number of recent significant wins in the NHS. Healthcare remains an important global market for Ideagen and we will continue to invest in healthcare-specific product development and complementary technology acquisitions to support our healthcare customers."

- See more at:

---

Well done to DH and team.

Regards,
GHF

[yump] 24/1/2014 07:37

I wonder how much this will drift now after the interims. Based on the fact that the previous level at 25-27 hardly moved around at all, would have thought 30p woudl be a good buy point. Just a theory I've got about shares that do steps, rather than jumping about. The implication is surely that existing investors are all very OK with the price.

[battlebus2] 24/1/2014 07:33

Yep a very interesting read ,thanks GHF.

[yump] 24/1/2014 07:29

Very unusual to actually hear the financial and growth strategy from a company in such a straightforward way !

As against the "we aim to totally change the way (insert name of market) operates, with our amazing game-changing products" BS.

[simon gordon] 21/1/2014 17:25

GHF,

Boy, that reads well.

Now the art, for me, is to sit and wait until 2020.

Thanks

[glasshalfull] 21/1/2014 17:13

Few interesting snippets in this article...


MIDLANDS BUSINESS NEWS
Ideagen bullish about growth prospects

By Edward Devlin, Midlands Correspondent
20 January 2014

Business
Derbyshire software supplier Ideagen's management team have told Insider they are confident about the company's outlook for its second half with revenue set to nudge closer to £10m.

The acquisitive company is also on the look out for further deals with ambitions to takeover one earnings enhancing business a year, chief executive David Hornsby and finance director Graeme Spenceley added.

Based in the Lime Tree Business Park in Matlock, Ideagen was admitted to AIM in July 2012.

Last week (14 January 2014), the business posted a 43 per cent rise in revenue to £3.7m in its first half. It was the ninth consecutive period of growth for the group. Pre-tax profit for the six months ended 31 October 2013 was also up from £230,403 to £515,105. Adjusted EBITDA increased by 59 per cent to £1.2m.
The strong organic underlying growth of 16 per cent was driven by a significant increase in revenue generated within the UK healthcare sector, Ideagen chief executive David Hornsby said at the time.

Full-year forecasts for adjusted EBITDA are £2.8m, slightly weighted towards the second half, with revenue set to grow by 42 per cent to £9m, which will include contribution from the latest acquisition, software developer MSS Management Systems Services.

Finance director Graeme Spenceley told Insider: "There is quite a lot in the pipeline and in procurement in terms of health service contracts already for the second half so we are confident where we think we'll be at the end of the full year."

Hornsby added that Ideagen was aiming to double the share price every three years as a baseline goal, which would put shares at about 60p each in 2017 and £1.20 by 2020.

He said if the company could continue to boost its earnings by about 20 per cent a year, grow organically by 10 per cent and complete one earnings enhancing acquisition then the ambition was attainable.

"We are certainly looking at further acquisitions in the next six to 12 months, but it will probably be in the next financial year," Hornsby said. "We are always open to deals and if something came very quickly out of nowhere and it was very attractive then we would have a look at it; particularly if it came out of cashflow."

The business has completed five transactions since 2011, including MSS in 2013 and Plumtree Group in 2012. It raised £6m at the time of the Plumtree deal from a placing to fund future acquisitions.

Hornsby and Spenceley both talked up the boost the business has received since its listing to AIM in 2012.

"The AIM listing has been very good," Hornsby said. "It has given us credibility and it has given us access to the capital markets. We used to be on Plus markets and we raised money on the promise from certain institutions that we would move to AIM. We raised £6m 12 months ago [at the time of the Plumtree deal], which we wouldn't have been able to do if we weren't on AIM.

"I think AIM has been a very good environment for us to grow."

Spenceley echoed the sentiments and the pair agreed the process wasn't for the faint hearted. However, Spenceley added that any company thinking of floating on AIM needs to use the market to their advantage.

"There is no point in going to AIM and then just sitting there and doing nothing," he said. "The whole point is the access to the capital market really. You need to have a requirement for capital, otherwise it is pointless."

---

Regards,
GHF

[glasshalfull] 16/1/2014 21:36

Thanks Simon - Balanced report I feel.

Another piece of positive news out today.


National Nuclear Laboratory adopts Workbench Enterprise to reach quality and compliance goals.

Ideagen PLC (AIM: IDEA), a leading supplier of compliance based Information Management, is pleased to announce that it has been awarded a contract with National Nuclear Laboratory (NNL).

hxxp://www.prweb.com/releases/2014/01/prweb11491673.htm

NNL is a highly important organisation in the global nuclear industry delivering a full range of research and technology services across the entire nuclear fuel cycle to a range of customers. The company also provides independent advice to the UK Government and other stakeholders as well as working with other National Laboratories around the world.

Ideagen's contract with NNL is to provide a next generation Integrated Management System (IMS) using Ideagen's Workbench Enterprise software. Fully integrated system 'dashboards' will provide NNL executives with real-time data, tracking quality and compliance-related Key Performance Indicators (KPI's). The new IMS will assist NNL in meeting statutory, regulatory and customer compliance requirements.

David Hornsby, Ideagen Chief Executive commented: "I am delighted that NNL has selected Workbench Enterprise to replace their Lotus Notes-based IMS, and we look forward to working alongside the NNL team to deliver service improvements and cost efficiencies over the project lifecycle."

He added, "Two further Ideagen projects at UK nuclear organisations are also showing good progress. We identified the resurgent Nuclear Energy sector as an emerging market opportunity 18 months ago and we are now seeing considerable interest for our solutions from the sector."

-Ends-


Regards,
GHF

[simon gordon] 16/1/2014 19:27

IC - 14/1/14:

Ideagen hunts for further acquisitions

Helping companies push paper around more efficiently is the name of the game for Ideagen (IDEA), a provider of information management software to highly regulated businesses. Its customers tend to be in sectors such as healthcare, aerospace and defence and finance, all of which have hefty reporting requirements.

Chief executive David Homsby has said he wants Ideagen to grow quickly, both organically and through acquisitions, and these results show just that. Underlying organic revenues climbed 16 per cent, while group-wide revenues soared 43 per cent, in line with expectations. Accordingly, adjusted pre-tax profits rose 58 per cent to £1.1m. The new MSS business was bedded into the healthcare division this period, while Pentana was acquired post period-end, providing an established foothold in the financial sector. That brings the total number of acquisitions since 2011 to five.

With cash starting to pour in from operations, Ideagen was able to declare a small maiden dividend. When asked about acquisition targets, Mr Homsby replied: "I always have a pipeline of opportunities, but it takes time. Certainly, we have enough cash to do another small acquisition".

Broker finnCap expects adjusted pre-tax profits of £2.6m and adjusted EPS of 1.7p in the current fiscal year, up from £1.9m and 1.5p in fiscal 2013. Sales are typically second-half weighted.

IC VIEW:

After a strong run of late, shares in Ideagen trade on 16 times forward earnings net of cash. That's only slightly above indebted peer Idox (IDOX) on 14 times forward earnings, and that company is coming off a profit warning in November. The price doesn't look excessive for a cash-generative software company experiencing double-digit organic revenue growth. Speculative buy.

[woodcutter] 15/1/2014 14:00

No problem GHF;-) that why were here, courtesy to reply though

Thanks simon, will take a look at FXD. I'm mainy using candles, i think you know that, but would like to add some indicator/oscillator confirmation struture if possible. I'm mainly using Stochastics, ADX, MACD and RSI at present to support the candlestick price action but they can be unreliable and the price action itself usually says more.

I looked at Ichimoku but the book reviews aren't that good so i've left alone for now.

WC

[bamboo2] 15/1/2014 13:41

Chart could be making a similar move as last time, ie pennant or flag, following the 50% ish retracement.

[battlebus2] 15/1/2014 13:32

Recovered a lot of yesterdays lost ground so far.

[yump] 15/1/2014 08:42

Its nice to read statements from a company that don't seem to have any vagueness in them. The more I look at the history, the more I like it. Seems to be a management that have good timing, a good strategy, can run the base business well and also report on it in a straightforward manner. Its a little early to apply the term 'great management' to IDEA, but all my best investments longer term had a very good reporting record. I don't mean perfect results, I mean open reporting. Perhaps that's evidence of when there is really good management. No overblown egos at work that start 'defending' their position with waffle, when results aren't quite up to scratch or telling stories of their 'world-changing' products.

Bit like interviewees really. The ones that sit there puffy-chested and make out they've led a team responsible for half their previous company's turnover, have usually just taken minutes in meetings.